Tag Archives: Best Practices

Evidence-based Tactics Impact TRx Growth

Co-pay and adherence programs continue to be the most effective tactics to drive TRx pull through Many pharmaceutical companies use co-pay cards and adherence programs as individual tactics in their patient support programs, but health care consultancies Best Practices, LLC

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It

“Troubleshooting” a Key Challenge of the Global Branding Process for New Bio-Pharma Products: Alignment Across Geographies

In the bio-pharmaceutical industry, it is no secret that different regions of the world have diverse regulatory and cultural environments. What is less apparent is that given these regional regulatory and cultural differences, pharmaceutical companies can have an effective global

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Much like many animals

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

Take a look at the slide below and see if you can answer which of the 5 drugs had a peak sales year of $13.7 billion. The answer? – Lipitor While Lipitor sold a gigantic $13.7 billion in their peak sales year,

Hotspots in Biopharma Digital Marketing Innovation

The rapid growth of digital, mobile and related technologies has transformed the global communications paradigm, and with it, changed the ways in which consumers and professionals access information. In case of the biopharmaceutical and medical device industry, the development of

Adopting the New Patient Journey Framework for Marketing

Marketing within the healthcare industry has been rapidly changing due to the growing influence of patients. Physicians are no longer the main focus in marketing when trying to determine market access and product launch success. Because patients are becoming more

Can Sovaldi’s Launch Success Be Repeated? Examining How Gilead Sciences Utilized Marketing Mix To Rewrite Launch History

We all know this story: Ninety-five percent of drugs in the development pipeline fail to clear the safety and efficacy profiles, and companies then add that R&D cost of such failures to the price of the drug that does reach the

Creating and Maintaining a Strategic KOL Management and Engagement System

Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small

Role of Medical Affairs Increasing in Oncology Launch

The Medical Affairs function plays a vital role in a host of oncology activities, including identification and engagement of Key Thought Leaders to guidance of commercial strategies and launch resources management. It is becoming increasingly apparent that a successful launch

Frustrations of a Pharmaceutical Market Researcher…

Not that long ago, I was updating a key research project here at Best Practices; and as usual, I was waiting on approval from our research manager. The approval delay made me agitated, but not nearly as much as when

Best Practices Hosts 7th Digital Marketing Consortium Roundtable

Best Practices hosted our 7th Digital Marketing Consortium Roundtable on Thursday, July 23. The topic of the virtual conference was “Key Trends & Innovative Activities in 2015 Biopharma Digital Marketing.” The roundtable brought together executives from 8 leading pharmaceutical companies